Raymond James Financial Upgrades Liquidia (NASDAQ:LQDA) to Strong-Buy

Posted by Geri Gentry on Nov 11th, 2026

Liquidia (NASDAQ:LQDA – Get Free Report) was upgraded by analysts at Raymond James Financial from an “outperform” rating to a “strong-buy” rating in a research report issued on Wednesday, Marketbeat reports. The firm presently has a $77.00 target price on the stock, up from their previous target price of $53.00. Raymond James Financial‘s price target would suggest a potential upside of 49.81% from the stock’s current price.

Several other brokerages have also recently commented on LQDA. Weiss Ratings raised shares of Liquidia from a “sell (d-)” rating to a “hold (c)” rating in a report on Tuesday, September 22nd. Royal Bank Of Canada set a $65.00 price target on Liquidia in a research note on Thursday, October 15th. Lifesci Capital upgraded Liquidia from a “hold” rating to an “outperform” rating and set a $59.00 price target for the company in a research note on Wednesday, October 14th. Bank of America increased their price target on Liquidia from $79.00 to $92.00 and gave the stock a “neutral” rating in a research report on Thursday, August 13th. Finally, Needham & Company LLC raised their price objective on Liquidia from $58.00 to $66.00 and gave the stock a “buy” rating in a research note on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, four have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, Liquidia has an average rating of “Hold” and an average target price of $76.77.

Get Our Latest Stock Report on Liquidia

Liquidia Trading Up 7.4%

LQDA stock opened at $51.40 on Wednesday. Liquidia has a 52 week low of $22.31 and a 52 week high of $93.61. The company has a market capitalization of $4.60 billion, a PE ratio of 37.52, a price-to-earnings-growth ratio of 0.42 and a beta of 0.40. The company’s 50-day simple moving average is $49.65 and its 200 day simple moving average is $54.53. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.12 and a current ratio of 2.31.

Liquidia (NASDAQ:LQDA – Get Free Report) last issued its quarterly earnings data on Tuesday, November 10th. The company reported ($2.64) earnings per share for the quarter, missing the consensus estimate of $0.96 by ($3.60). The business had revenue of $225.30 million during the quarter, compared to analyst estimates of $214.18 million. Liquidia had a return on equity of 149.65% and a net margin of 30.74%. Liquidia’s revenue for the quarter was up 314.9% compared to the same quarter last year. During the same quarter last year, the firm earned ($0.04) EPS. As a group, sell-side analysts anticipate that Liquidia will post 2.05 earnings per share for the current year.

Insider Activity at Liquidia

In related news, insider Jason Adair sold 73,631 shares of the company’s stock in a transaction on Friday, August 21st. The stock was sold at an average price of $69.09, for a total transaction of $5,087,165.79. Following the completion of the sale, the insider directly owned 174,606 shares in the company, valued at $12,063,528.54. This represents a 29.66% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stephen Bloch sold 235,477 shares of the firm’s stock in a transaction dated Monday, October 5th. The shares were sold at an average price of $27.13, for a total value of $6,388,491.01. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 566,579 shares of company stock worth $25,746,120 in the last three months. Insiders own 25.60% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Nisa Investment Advisors LLC lifted its stake in shares of Liquidia by 13.8% in the 3rd quarter. Nisa Investment Advisors LLC now owns 2,634 shares of the company’s stock valued at $80,000 after acquiring an additional 320 shares during the last quarter. Pinnacle Wealth Planning Services Inc. increased its holdings in Liquidia by 26.2% in the 3rd quarter. Pinnacle Wealth Planning Services Inc. now owns 1,557 shares of the company’s stock worth $47,000 after purchasing an additional 323 shares in the last quarter. Hanseatic Management Services Inc. raised its position in Liquidia by 2.0% in the third quarter. Hanseatic Management Services Inc. now owns 21,733 shares of the company’s stock valued at $658,000 after purchasing an additional 435 shares during the last quarter. Quantinno Capital Management LP raised its position in Liquidia by 3.6% in the first quarter. Quantinno Capital Management LP now owns 17,165 shares of the company’s stock valued at $648,000 after purchasing an additional 589 shares during the last quarter. Finally, Oregon Public Employees Retirement Fund boosted its stake in shares of Liquidia by 4.4% during the third quarter. Oregon Public Employees Retirement Fund now owns 16,700 shares of the company’s stock valued at $505,000 after purchasing an additional 700 shares in the last quarter. 64.54% of the stock is currently owned by institutional investors and hedge funds.

Key Stories Impacting Liquidia

Here are the key news stories impacting Liquidia this week:

Positive Sentiment: YUTREPIA generated $222.7 million in third-quarter sales, helping lift total revenue to $225.3 million—up 314.9% year over year and ahead of analysts’ estimates. Adjusted EPS was reported at $0.80, above the $0.77 consensus. Liquidia Q3 Earnings and Revenues Beat Estimates
Positive Sentiment: Reports said litigation was resolved, potentially reducing a significant source of uncertainty for the company. Shares reportedly rose following the results and legal update. Liquidia rises after third-quarter results, litigation resolved
Positive Sentiment: BTIG raised its price target to $87 from $70 and maintained a Buy rating, reflecting a more bullish analyst outlook. BTIG Research ratings
Negative Sentiment: Despite the adjusted-earnings beat, Liquidia reported a GAAP loss of $2.64 per share, versus expectations for a profit. A $389.7 million charge reportedly masked the strong sales quarter, so investors may focus on its impact and the company’s underlying earnings outlook. A charge masks a booming YUTREPIA quarter

About Liquidia

(Get Free Report)

Liquidia Corporation is a biopharmaceutical company focused on developing and commercializing treatments for pulmonary hypertension and other serious diseases. Its work includes inhaled therapies designed to deliver medicines to the lungs. The company’s marketed product, Yutrepia (treprostinil) inhalation powder, is approved in the United States for adults with pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. Liquidia also has a pipeline of investigational therapies, including other formulations of treprostinil.